# EDGAR Filing Document

**Accession Number:** 0000882291
**File Stem:** 0001683168-25-006559
**Filing Date:** 2025-8
**Character Count:** 2904
**Document Hash:** caee284d1ad98bf96e212cfb385623c2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-006559.hdr.sgml**: 20251120

**ACCESSION NUMBER**: 0001683168-25-006559

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AETHLON MEDICAL INC
- **CENTRAL INDEX KEY:** 0000882291
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 133632859
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 11555 SORRENTO VALLEY ROAD, SUITE 203
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** 619-941-0360

**MAIL ADDRESS:**
- **STREET 1:** 11555 SORRENTO VALLEY ROAD, SUITE 203
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BISHOP EQUITIES INC
- **DATE OF NAME CHANGE:** 19930602

Aethlon Medical, Inc.<br> 11555 Sorrento Valley Road, Suite 203

San Diego, CA 92121<br> (619) 941-0360

August 29, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | Aethlon Medical, Inc. |
|  | Registration Statement on Form S-1, as amended |
|  | File No. 333-289745 |
|  | <br> **REQUEST FOR ACCELERATION OF EFFECTIVENESS** |

---

Ladies and Gentleman:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), Aethlon Medical, Inc., a Nevada corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-1, as amended (File No. 333-289745), to become effective on Tuesday, September 2, 2025, at 5:01 p.m.., Eastern Time, or as soon thereafter as is practicable.

The Registrant understands that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.

The Registrant hereby authorizes its counsel, Dennis Doucette, Esq. of Procopio, Cory, Hargreaves & Savitch LLP, to orally modify or withdraw this request for acceleration. Please contact Mr. Doucette at (858) 720-6322 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.

---

| | |
|:---|:---|
| Very Truly Yours, | Very Truly Yours, |
| **Aethlon Medical, Inc.** | **Aethlon Medical, Inc.** |
| By: | /s/ Jim Frakes |
| Name: Jim Frakes | Name: Jim Frakes |
| Title: Chief Executive Officer | Title: Chief Executive Officer |

---